Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 10Terminated 6Recruiting 4Withdrawn 3Unknown 3Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 19Lymphoid 8Other hematologic neoplasm 7Breast 2Thoracic 1Gastrointestinal 1CNS 1

Conditions

Brain Neoplasms 1

Interventions

Temozolomide 21Magnetic Resonance Spectroscopy 9Radiotherapy 8Blood Specimen Collection 8Cyclophosphamide 6Bevacizumab 6AZD 6244 6pembrolizumab 5Specimen Handling 4Radiation 4fludarabine 3dinutuximab 3aflutinib 3Surgical Procedures, Operative 3Saline Solution 3Radiotherapy, Intensity-Modulated 3Pemetrexed 3Granulocyte-Macrophage Colony-Stimulating Factor 3vorasidenib 2tislelizumab 2osimertinib 2naxitamab 2gallium maltolate 2fludarabine phosphate 2cemiplimab 2Topotecan 2Standard of Care 2Spinal Puncture 2Receptors, Interleukin-8B 2Radiosurgery 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Dexamethasone × CNS × Clear all
NCT07542288 2026-04-21

Comparison of the Therapeutic Effects of Methylprednisolone and Dexamethasone on Peritumoral Edema During Radiotherapy for Brain Metastases:

The Second Affiliated Hospital of Hainan Medical University

Phase 2/3 Not yet recruiting
400 enrolled
CNS

Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡